Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer has enlisted McCann HumanCare to help launch Chantix, a new prescription smoking-cessation drug, the agency said today.
Chantix will debut later this year. Estimated media spending is $75 million, according to sources.
McCann HumanCare is the health and wellness arm of Interpublic Group’s McCann Erickson in New York.
The account was awarded after a review in which at least two other undisclosed agencies participated.
In a statement, Andrew Shirmer, managing director of McCann HumanCare, said, “We are delighted with the huge opportunity to help people quit smoking and help market Chantix.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in